va

VA-K-14 hydrochloride(VAK14 HCl) is a selective thyrotropin receptor (TSHR) antagonist (IC50= 12.3 μM) that inhibits TSHR stimulation by serum and monoclonal TSHR-stimulating antibodies from patients with GD and abrogates TSHR signaling.

DBCO-PEG4-VA-PBD is a cleavable 4-unit PEG ADC linker utilized in antibody-drug conjugate (ADC) synthesis [1].

Mal-PEG4-VA-PBD is a drug-linker conjugate for Antibody-Drug Conjugates (ADCs), consisting of the antitumor antibiotic Pyrrolobenzodiazepine (PBD) linked via Mal-PEG4-VA.

Mal-PEG4-VA, a noncleavable ADC linker featuring a Maleimide group, is utilized in the synthesis of antibody-drug conjugates.

VA5 is an transamidase inhibitor by direct binding at the transamidase site. VA5 also inhibits GTP-binding activities. It interaction at the transamidase site locks the protein in the extended/open conformation to disorganize/inactivate the GTP binding/GT

VAS 3947 is a specific inhibitor of NADPH oxidase (NOX).VAS 3947 has a potent anti-platelet effect, inducing apoptosis through UPR activation, mainly due to protein aggregation and misfolding, independent of anti-NOX activity.

Z-VA-DL-D-FMK (Z-VA-DL-D(OH)-FMK) acts as an inhibitor of caspases. It irreversibly binds to caspases, enhancing the sensitivity to TNF-α and stimulating HIV replication in infected T cells ACH-2.

Retinyl acetate (Vitamin A acetate) is a group of unsaturated nutritional hydrocarbons, that contains retinal, retinol, retinoic acid, and several provitamins A carotenoids, among which beta-carotene is the most important.

β-Carotene (Provitamin A) is a naturally-occurring retinol (vitamin A) precursor obtained from certain fruits and vegetables with potential antineoplastic and chemopreventive activities. As an anti-oxidant, beta carotene inhibits free-radical damage to DNA.

MP-PEG8-VA-PABC-PBD Dimer is a drug-linker conjugates for ADC which is used in the treatment of several cancers. PBD Dimer is a DNA alkylating which inhibits DNA replication[1].

OAT-1441 is a hAMCase inhibitor.

1. Eriocitrin (Eriodictyol-7-O-Rutinoside) is powerful antioxidative flavonoid; (1) Prevents oxidative damages caused by acute exercise-induced oxidative stress.(2) Lipid-lowering effects in a rat model of high-fat diet. 2. Dietary Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis. 3. Eriocitrin and Apigenin were identified as new potent inhibitors of human carbonic anhydrase VA isozyme.

MC-VA-PAB-PNP is a cleavable ADC linker that can be used for the synthesis of antibody-conjugated active molecules (ADCs).

Mal-PEG8-VA-PAB-PNP is a degradable, hydrophilic linker that can be used in the synthesis of ADCs.

Fmoc-VA-PAB-PNP is a cleavable linker with an Fmoc protecting group, which can be used in the synthesis of ADCs.

MC-VA-PAB-MMAD is a thiol-reactive Drug-linker. MMAD is an effective microtubule (tubulin) inhibitor, which is commonly used in the synthesis of antibody-drug conjugates (ADCs).

VA-PAB-DMEA-PNU159682 is a transpeptidase reaction-type Drug-linker with an innovative highly stable and degradable linker. PNU159682 is a DNA topoisomerase II (Topo II) inhibitor with excellent cytotoxicity and can be used in the synthesis of antibody-drug conjugates (ADCs).

MC-PEG2-VA-PAB-Exatecan (Compound DL-18) is a drug-linker conjugate designed for use in antibody-drug conjugates (ADC). It consists of Exatecan and a linker. This compound is utilized in the synthesis of ADCs.

DBCO-PEG4-VA-PABC-MMAE is a drug-linker conjugate for ADCs, consisting of a tubulin inhibitor (MMAE) and a cleavable linker (DBCO-PEG4-VA-PABC). This compound is applicable for synthesizing ADCs.

BCN-HS-PEG2-VA-PABC is an ADC linker used in the synthesis of PL1601.

DBCO-HS-PEG2-VA-PABC-SG3199 is a drug-linker conjugate for ADC (antibody-drug conjugate) that features a SG3199-based DNA minor groove cross-linking agent and a cleavable linker. This compound is suitable for the synthesis of ADCs.

MC-VA-PABC-MMAE is a conjugate composed of the ADC linker peptide MC-VA-PABC and the cytotoxic agent monomethyl auristatin E (MMAE), a potent inhibitor of tubulin polymerization [1] [2]. It functions as an agent-linker module for antibody-drug conjugates (ADCs).

MC-VA-PAB-Exatecan is a drug-linker conjugate used for synthesising ADCs, containing an ADC linker (MC-VA-PAB) and the topoisomerase I inhibitor Exatecan, which exhibits antitumour activity.

SA-VA, an intracellular self-assembled PROTAC featuring azide and alkyne groups, selectively degrades VEGFR-2 and EphB4 proteins within U87 cells. This compound undergoes in situ conversion to active PROTAC via a copper-catalyzed click reaction utilizing endogenous copper present in tumor tissues. Additionally, SA-VA induces apoptosis and arrests cell cycle progression in the S phase [1].